Long-Term Costs Associated with Anti-Cyclic Citrullinated Peptide Positivity in Patients with Rheumatoid Arthritis
May 1, 2018, 00:00
10.1016/j.jval.2018.04.835
https://www.valueinhealthjournal.com/article/S1098-3015(18)31135-5/fulltext
Title :
Long-Term Costs Associated with Anti-Cyclic Citrullinated Peptide Positivity in Patients with Rheumatoid Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31135-5&doi=10.1016/j.jval.2018.04.835
First page :
Section Title :
Open access? :
No
Section Order :
140